Site logo
Sticky header logo
Mobile logo
  • Home
  • About Us
    • Why Solara
    • Values
    • Leadership Team
  • Capabilities
    • Research & Development
      • R&D – Analytical
      • R&D – Chemistry
      • R&D – Process
    • Quality
  • Service Offerings
    • Synthetic Development Services
    • Analytical Development Services
    • Process Engineering
    • Kilo Lab
    • Regulatory Services
  • Facilities/Infrastructure
  • Blogs
  • Contact us
NextThe Trends Of Active Pharmaceutical Ingredient (API) Manufacturing Industry12 August 2019
  • Information

Contract Research and Manufacturing Services (CRAMS) – Where Do India Stand?

August 6, 2019in Information 0 Comments 17 Likes

Contract Research and Manufacturing Services over the last couple of decades have changed the way how Pharma and Biotechnology industries have been functioning. The answer to this change is clearly visible in the way this industry has grown in the period. CRAMS, as a service, is primarily research and manufacturing outsourcing and delivery models offered by CROs (Contract Research Organizations) and CMOs (Contract Manufacturing Organizations).

Some of the major factors that have attributed to the evolution of this outsourcing model in research and manufacturing spaces include – Burgeoning research and development costs, Decreasing productivity as a result of greyish outcome possibilities, Lack of manufacturing capacity and resources etc. The numbers says it all. As of 2018, over 60% of all Pharma related manufacturing and research were outsourced.

CRAMS – The Indian Story

Pharmaceutical manufacturing and research have always been topics of debate as a result of their shear nature, which attract stringent regulation and close scrutiny form policy makers and industry regulators.

This industry makeover has evidently highlighted the rise of Indian CRAMS organizations, which have emerged as front runners for API manufacturing and the delivery of intricate chemistry services. Additionally, the continued economic crunch along with the unremitting pricing pressure and pro-generic agenda are driving Pharma companies to leverage the strengths of Indian Pharma manufacturers.

As more and more Pharma companies looking to drive growth, while mitigate the effects of the industry challenges, seeking services of contract manufacturers. India, South Africa, South East Asia is witnessing a steady rise in organizations offering such services. India alone is looking at a compounded year or year growth of 17 to 18 percent growth in Pharma contract manufacturing and research industry.

On a reflective note, the emergence of Indian CRAMS is inevitable for it has a long and successful history in knowledge intensive industries such as IT, Technology etc. In addition to this, India has the largest bracket of professionals who are proficient in English and highest no of chemistry and manufacturing graduates entering the workforce every year. Furthermore, India has the highest number of FDA approved manufacturing sites outside India and the number is over a hundred as of year 2019. Quality delivery of CRAM services with value on prices have definitely let to India being among the top destinations for manufacturing and research services in Pharma.

Summary

For any businesses to sustain and flourish, strategic cost transformation while delivering commercial value to customers is a must. CRAMS is exactly doing that for its clients from across the globe. India, as a CRAMS destination has grabbed on to the opportunity bandwagon without a miss and is expected to take strides northwards from here.

17 Likes
Leave a Reply

Click here to cancel reply.

Your email address will not be published. Required fields are marked *

Subscribe

Recent Posts

  • Multi-Steps Synthesis Organometallic and Photo Reactions | All you need to know
  • Solara’s contribution to Photochemistry
  • Solara’s contribution to Polymer Chemistry
  • The Trends Of Active Pharmaceutical Ingredient (API) Manufacturing Industry
  • Contract Research and Manufacturing Services (CRAMS) – Where Do India Stand?

About SolaraCRAMS

Solara Active Pharma Sciences offers Contract Research and Manufacturing and Development Services across the entire value chain of a new chemical entity which covers from Pre-Clinical to Commercial Phase. We have a strong team of 200+ scientists functioning from two research centers which are supported by a highly compliant manufacturing footprint spread over five large scale multi-product facilities.

Our Capabilities

  • Chemistry R&D
  • Analytical R&D
  • Process R&D
  • Quality

Our Services

  • Synthetic Development
  • Analytical Development
  • Process Engineering
  • Kilo Lab
  • Regulatory

ABOUT US

Solara Active Pharma Sciences offers Contract Research and Manufacturing and Development Services across the entire value chain of a new chemical entity which covers from Pre-Clinical to Commercial Phase. We have a strong team of 200+ scientists functioning from two research centers which are supported by a highly compliant manufacturing footprint spread over five large scale multi-product facilities.

Contact us

Solara Active Pharma Sciences Limited
2nd Floor, Embassy Vogue, Palace Road,
Vasanth Nagar, Bangalore – 560052, Karnataka, India
Phone: +91 80 46632100
Email: crams@solara.co.in

Important Links

  • About Us
  • Facilities
  • Contact Us
  • Privacy Policy
  • Sitemap
© Solara. All rights reserved.